跳至主要内容
临床试验/CTRI/2026/03/106017
CTRI/2026/03/106017尚未招募3 期

A Randomized Controlled Trial to Evaluate the Effect of Vidangadi Churna in Comparison with Pippalyadi Churna in Reducing Liver Fat Accumulation in Adults with Non Alcoholic Fatty Liver Disease (NAFLD)

Dr Kavita Rambhau Bhagat1 个研究点 分布在 1 个国家目标入组 54 人开始时间: 2026年3月23日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
54
试验地点
1

研究概览

简要总结

This study involves 54 participants randomized into two equal groups (n=27 each) to compare the efficacy of two formulations over a 90-day period. Group A: Receives Vidangadi Churna twice daily, administered orally with lukewarm milk after meals. Group B: Receives Pippalyadi Churna twice daily, administered orally with lukewarm water after meals.  Clinical assessments will be conducted at 30, 60, and 90 days to evaluate progress. Final results will be determined based on predefined assessment criteria.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant Blinded

入排标准

年龄范围
25.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • 1.Patients aged between 25 and 60 years, irrespective of sex, occupation, or economic status.
  • 2.Radiological evidence of fatty infiltration of the liver confirmed by abdominal Ultrasonography (USG) or other imaging modalities such as Contrast-Enhanced Computed Tomography (CECT).
  • 3.Presence of clinical signs and symptoms suggestive of NAFLD (Yakrut Roga) such as loss of appetite, pain in the right upper quadrant or epigastric region, and nausea.

排除标准

  • 1.Patients with alcohol intake exceeding 20 mL per day (history of alcohol intake was taken separately from the patients and close relatives) 2.Patients with positive diagnostic markers for other liver diseases such as Viral Hepatitis, Autoimmune Hepatitis, Wilson’s Disease, Hemochromatosis.
  • 3.Patients currently dependent on steroids or analgesic medications, or those who have participated in any other clinical trial within the last 6 months.
  • 4.Patients who have undergone major surgery within 2 weeks prior to the screening visit.

研究者

发起方
Dr Kavita Rambhau Bhagat
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Kavita Rambhau Bhagat

Shri Ayurved Mahavidyalaya, Hanuman Nagar, Nagpur 440024 Maharashtra India

研究点 (1)

Loading locations...

相似试验